Information | Â | Australia n/58 (%) | Malaysia n/125 (%) |
---|---|---|---|
Approved product information sheet given | Yes | 31 (53) | 97 (78) |
 | No | 27 (47) | 28 (22) |
 |  | ^P < 0.001 |  |
Indications | Yes | 52 (90) | 116 (93) |
 | No | 6 (10) | 7 (5) |
 | Unsure | 0 | 2 (2) |
 |  | ^*P = 0.33 |  |
Dosage | Yes | 44 (76) | 103 (82) |
 | No | 14 (24) | 22 (18) |
 |  | ^P = 0.30 |  |
Contraindications | Yes | 19 (33) | 50 (40) |
 | No | 37 (64) | 72 (58) |
 | Unsure | 2 (3) | 3 (2) |
 |  | ^*P = 0.37 |  |
Precautions | Yes | 21(36) | 38 (30) |
 | No | 34 (59) | 82 (66) |
 | Unsure | 3 (5) | 5 (4) |
 |  | ^*P = 0.40 |  |
Drug interactions | Yes | 19 (33) | 31 (25) |
 | No | 38 (65) | 89 (71) |
 | Unsure | 1 (2) | 5 (4) |
 |  | ^*P = 0.30 |  |
Adverse effects | Yes | 24 (41) | 45 (36) |
 | No | 33 (57) | 73 (58) |
 | Unsure | 1 (2) | 7 (6) |
 |  | *P = 0.61 |  |
Did the representative answer your questions on contraindications, precautions, drug interactions, adverse effects? | Yes | 34/45 (76) | 60/105 (57) |
 | No | 2/45 (4) | 7/105 (7) |
 | Partly | 9/45 (20) | 38/105 (36) |
 | No question asked | 13 | 20 |
 |  | ^&P = 0.10 |  |
Given the nature of the drug detailed, do you think the representative should have mentioned contraindications, precautions for use, drug interaction or adverse effects spontaneously? | Yes | 35 (60) | 106 (85) |
 | No | 23 (40) | 19 (15) |
 |  | ^P < 0.001 |  |